Report Description The research report identifies the key driving factors of the asthma therapeutics market as the rising environmental pollution that adversely affects the respiratory system of the human body, causing asthma and other respiratory diseases. Rapidly growing industrialization and globalization have led to an imbalance in the environmental constitution. One of the most conspicuous trends in this market is the adoption of a combination of therapies for the treatment of asthma patients. This technique can further help asthma patients by controlling inflammation caused in the respiratory tract. However, the biggest challenge faced by the drug producers is the etiology of respiratory diseases owing to which developing the remedy becomes a tough job. Advair – an eminent asthma therapeutic product is the highly selling drug which is manufactured by GlaxoSmithKline plc. After Advair, the Symbicort drug manufactured by AstraZeneca holds the second position in selling asthma drugs in the global asthma therapeutics market. Complete Report with TOC @ http://www.mrrse.com/asthma-therapeutics-market .

1. Asthma Therapeutics Market to 2020
Published By:
GBI Research Market
Research
Contact US:
Tel: +1-518-618-1030
Email: sales@mrrse.com
Toll Free : 866-997-4948 (US-
CANADA)

2. Report Description
The research report identifies the key driving factors of the asthma therapeutics market as
the rising environmental pollution that adversely affects the respiratory system of the
human body, causing asthma and other respiratory diseases. Rapidly growing
industrialization and globalization have led to an imbalance in the environmental
constitution.
One of the most conspicuous trends in this market is the adoption of a combination of
therapies for the treatment of asthma patients. This technique can further help asthma
patients by controlling inflammation caused in the respiratory tract. However, the biggest
challenge faced by the drug producers is the etiology of respiratory diseases owing to which
developing the remedy becomes a tough job.
Advair – an eminent asthma therapeutic product is the highly selling drug which is
manufactured by GlaxoSmithKline plc. After Advair, the Symbicort drug manufactured by
AstraZeneca holds the second position in selling asthma drugs in the global asthma
therapeutics market.
Complete Report with TOC @ http://www.mrrse.com/asthma-therapeutics-market .

3. Scope
The global market for asthma therapeutics is expecting substantial growth in the near future
amongst the eight leading developed economies. The global predominance of asthma is
increasing everyday which is expected to affect millions of people across the globe. As per
figures provided by WHO, in 2011 around 23 million globally people were affected by asthma
and the number of asthma patients is expected to increase in the near future.
In 2013, the global market for asthma therapeutics stood at US$18.4 billion and is anticipated
to touch US$21.7 billion by the end of 2020 exhibiting a progressive 2.4% CAGR through the
forecast period. The revenue figures are rising despite the generic erosion that is faced by
many key asthma drug brands such as Symbicort (budesonide/formoterol fumarate), Xolair
(omalizumab), and Advair (fluticasone propionate/salmeterol xinafoate). Another reason for
the increasing demand in asthma therapeutics market is an influx of new entrants in the global
market and the rising number of respiratory diseases.

4. Key Players
Some of the key players of the global asthma therapeutics market are GlaxoSmithKline plc,
Merck & Co. Inc., Novartis AG, AstraZeneca plc, and F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc (GSK) is the topmost seller of drugs of the of the global asthma
therapeutics market.
The British multinational company which was formed in 2000 is the largest drug and vaccine
manufacturer for major diseases such as infections, digestive, asthma, mental health
conditions, diabetes, and cancer.
Request a Sample Copy of the Report @ http://www.mrrse.com/sample/106 .

5. Corporate Office
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
Email: sales@mrrse.com
Toll Free : 866-997-4948 (US-CANADA)
Contact Us
Read More @ http://www.mrrse.com/